| Literature DB >> 29258255 |
Jiankuan Li1, Tao Wang2, Zhichuan Zhu3, Fengrong Yang4, Lingya Cao5, Jianping Gao6.
Abstract
Radix Codonopsis has been used in traditional Chinese medicine for strengthening the immune system, improving poor gastrointestinal function, treating gastric ulcers and chronic gastritis and so on. In the present study, an inulin-type fructan CP-A was obtained from the roots of Codonopsis pilosula (Franch.) Nannf. and its structure was confirmed by MS and NMR as (2 → 1) linked-β-d-fructofuranose. The protective effects of CP-A against ethanol-induced acute gastric ulcer in rats were intensively investigated. A Lacy assay demonstrated that CP-A-treated group (50 mg/kg) showed the gastric damage level 1, which was similar to the positive control group, while the model group exhibited the gastric damage level 3. The Guth assay demonstrated that the mucosa ulcer index for CP-A groups at the doses of 50 mg/kg and 25 mg/kg significantly decreased compared with that in the model group (p < 0.05). Meanwhile, CP-A significantly increased the activities of SOD and GSH-Px, and decreased the contents of MDA and NO, and the activity of MPO in gastric tissue in a dose-dependent manner (p < 0.05). The present research reported for the first time that inulin-type fructan CP-A were likely the potential component in Radix Codonopsis for treatment of acute gastric ulcers.Entities:
Keywords: Codonopsis pilosula (Franch.) Nannf.; carbohydrate; gastric ulcer; inulin-type fructan; structure determination
Mesh:
Substances:
Year: 2017 PMID: 29258255 PMCID: PMC6149740 DOI: 10.3390/molecules22122258
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1HPGPC curve (A) and MALDI-TOF mass spectrum (B) of CP-A.
Figure 21H-NMR (A); 13C-NMR (B) and DEPT135 (C) spectra of CP-A.
Figure 3HSQC spectrum of CP-A.
Figure 4HMBC spectrum of CP-A.
Figure 5Morphological appearance of different treatments against ethanol-induced gastric lesions. (A) Normal; (B) Ethanol; (C) CP-A 50 mg/kg + Ethanol; (D) CP-A 25 mg/kg + Ethanol; (E) CP-A 12.5 mg/kg + Ethanol and (F) BPC + Ethanol.
Figure 6Histological sections of different treatments against ethanol-induced gastric lesions (Original magnification 200×). (A) Normal; (B) Ethanol; (C) CP-A 50 mg/kg + Ethanol; (D) CP-A 25 mg/kg + Ethanol; (E) CP-A 12.5 mg/kg + Ethanol and (F) BPC + Ethanol.
Figure 7Effect of CP-A on ulcer index in ethanol-induce rat gastric mucosal. Data are presented as mean ± SD (n = 10). * p < 0.05 versus Normal group; # p < 0.05 versus Ethanol group.
Figure 8Effect of CP-A on MDA content (A); GSH-Px (B); SOD (C); MPO activity (D); and NO level (E) in ethanol-induce gastric mucosal. Data are presented as mean ± SD (n = 10). * p < 0.05 versus Normal group; # p < 0.05 versus Ethanol group.